Seasoned European investment professional and former operating executive focused on buyouts, growth equity and corporate finance advisory. Philippe Reitzer brings cross-border deal experience, portfolio company oversight, and capital-raising expertise to institutional investors and corporate boards. Known for sourcing mid-market opportunities, executing operational turnarounds and structuring complex financing solutions, he is active in value-creation programs and board governance, with a background spanning investment banking, private equity and operational leadership.
Seasoned European investment professional and former operating executive focused on buyouts, growth equity and corporate finance advisory. Philippe Reitzer brings cross-border deal experience, portfolio company oversight, and capital-raising expertise to institutional investors and corporate boards. Known for sourcing mid-market opportunities, executing operational turnarounds and structuring complex financing solutions, he is active in value-creation programs and board governance, with a background spanning investment banking, private equity and operational leadership.
Adopts a pragmatic, value-oriented private markets approach combining operational playbooks with structured finance to unlock mid-market opportunities across Europe. Focuses on buyouts and growth equity where operational interventions and tailored capital structures increase cash flow and accelerate scalable growth. Prefers cross-border situations, complex carve-outs and turnaround engagements; emphasizes thorough due diligence, active board-level oversight, and KPI-driven management plans. Capital deployment favors control or significant minority positions with 3–7 year horizons, disciplined leverage, staged financing and clear exit pathways to maximize risk-adjusted returns.
Adopts a pragmatic, value-oriented private markets approach combining operational playbooks with structured finance to unlock mid-market opportunities across Europe. Focuses on buyouts and growth equity where operational interventions and tailored capital structures increase cash flow and accelerate scalable growth. Prefers cross-border situations, complex carve-outs and turnaround engagements; emphasizes thorough due diligence, active board-level oversight, and KPI-driven management plans. Capital deployment favors control or significant minority positions with 3–7 year horizons, disciplined leverage, staged financing and clear exit pathways to maximize risk-adjusted returns.
| Trades 2552 | Longs Won 1569/2552 61% | Profit Factor 3.34 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $6.49M |
| Average Win $996,866.27 | Best Trade (Aug 28) $228.53M | Sharpe Ratio -14.94 |
| Average Loss -$476,607.67 | Worst Trade (Jun 30) -$55.37M | Z-Score 1.66 (90.37%) |
| Commissions $0 | Avg. Trade Length 6m 5d | Expectancy $429,266.41 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 10,000 | 9,000 | 8,000 | 7,000 | 6,000 | 5,000 | 4,000 | 3,000 | 2,000 | 1,000 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 400 | $46,792 | $55,348 | - | $8,556 | 18.29% | -0.245% |
AAPL Apple Inc. | 1.06M | $238.43M | $327.58M | - | $89.15M | 37.39% | -7.354% |
ABBV AbbVie Inc. | 5,858 | $1.27M | $1.47M | - | $201,271.06 | 15.86% | -2.513% |
ABT Abbott Laboratories | 31,530 | $3.78M | $3.33M | - | -$444,442.31 | -11.77% | +0.085% |
ACGL Arch Capital Group Ltd | 3,396 | $311,110.61 | $341,399.88 | - | $30,289.27 | 9.74% | -0.603% |
ACN Accenture plc Class A | 5,948 | $1.17M | $986,892.16 | - | -$185,394.44 | -15.81% | +1.611% |
ACWI iShares MSCI ACWI ETF | 60 | $9,418 | $9,385.8 | - | -$32.2 | -0.34% | +0.495% |
ADBE Adobe Inc. | 18,289 | $6.55M | $4.58M | - | -$1.98M | -30.13% | +1.013% |
ADI Analog Devices, Inc. | 1,680 | $535,327.83 | $617,248.8 | - | $81,920.97 | 15.3% | +0.202% |
ADSK Autodesk, Inc. | 348 | $77,495.64 | $81,501.6 | - | $4,005.96 | 5.17% | -0.328% |
AEM Agnico Eagle Mines Limited | 48 | $8,645.63 | $6,972.96 | - | -$1,672.67 | -19.35% | -3.635% |
AEP American Electric Power Company, Inc. | 180 | $16,509 | $23,013 | - | $6,504 | 39.4% | +0.055% |
AEYE AudioEye, Inc. | 100 | $603 | $579 | - | -$24 | -3.98% | -0.686% |
AIG American International Group Inc. | 6,640 | $499,660 | $521,771.2 | - | $22,111.2 | 4.43% | -0.393% |
AIQ Global X Artificial Intelligence & Technology ETF | 11,928 | $782,596 | $702,439.92 | - | -$80,156.08 | -10.24% | +0.341% |
ALAB ASTERA LABS INC COMMON STOCK (Ticker: 1ALAB) | 10,794 | $1.18M | $3.36M | - | $2.18M | 184.04% | +3.851% |
ALC Alcon Inc. | 91 | $6,733 | $6,273.54 | - | -$459.46 | -6.82% | -0.963% |
ALGN Align Technology, Inc. | 29 | $4,606.94 | $4,905.64 | - | $298.7 | 6.48% | -2.451% |
ALLE Allegion plc | 8,043 | $1.17M | $1.27M | - | $98,245.88 | 8.41% | +0.216% |
ALNY Alnylam Pharmaceuticals Inc | 692 | $224,486.55 | $142,219.84 | - | -$82,266.71 | -36.65% | +0.019% |